CLX vs KMB
Clorox and Kimberly-Clark, both Consumer Defensive
Kimberly-Clark is the larger company at $34B against $12B. Over the past year KMB returned -19% against -30% for CLX. The RyuScore puts CLX ahead, 68 against 66 out of 100.
| Figure | CLX | KMB |
|---|---|---|
| Last close | $83.80 | $97.60 |
| Market cap | $12B | $34B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | n/a | 16.6 |
| Dividend yield | 5.8% | 5.2% |
| 1-year return | -30% | -19% |
| 5-year return | -42% | -15% |
| RyuScoresector-relative, 1–10 | 68/100 | 66/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Clorox
Kimberly-Clark
Revenue of $4.2B in Q2 2026, net income $345M. Its largest reported line is Babyandchildcareproducts, 42% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or see the correlation.